HIP2B
Sponsors
CureDM
Conditions
HealthyType 2 Diabetes Mellitus
Phase 1
A Study of Subcutaneous Doses of HIP2B in Healthy Male Subjects
CompletedNCT01638611
Start: 2012-07-31End: 2012-09-30Updated: 2016-11-15
Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin
CompletedNCT01933256
Start: 2013-08-31End: 2014-12-31Updated: 2016-11-15